UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 66 filers reported holding UNIQURE NV in Q4 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $617 | -47.0% | 53,877 | -6.9% | 0.01% | -55.6% |
Q1 2023 | $1,165 | +34.1% | 57,867 | +50.9% | 0.03% | +8.0% |
Q4 2022 | $869 | -99.6% | 38,350 | +755.1% | 0.02% | +316.7% |
Q2 2020 | $202,000 | -1.9% | 4,485 | +3.5% | 0.01% | -25.0% |
Q1 2020 | $206,000 | -60.2% | 4,332 | -92.0% | 0.01% | -57.9% |
Q3 2017 | $518,000 | +55.1% | 54,000 | 0.0% | 0.02% | +35.7% |
Q2 2017 | $334,000 | +5.0% | 54,000 | -1.8% | 0.01% | +7.7% |
Q1 2017 | $318,000 | +278.6% | 55,000 | +266.7% | 0.01% | +225.0% |
Q4 2016 | $84,000 | -29.4% | 15,000 | +50.0% | 0.00% | -20.0% |
Q1 2016 | $119,000 | -64.0% | 10,000 | -50.0% | 0.01% | -78.3% |
Q4 2015 | $331,000 | +35.1% | 20,000 | +66.7% | 0.02% | +109.1% |
Q3 2015 | $245,000 | +21.9% | 12,000 | -6.8% | 0.01% | +175.0% |
Q1 2014 | $201,000 | – | 12,882 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |